Ensitrelvir by Shionogi & Co. is a highly effective antiviral drug that works just as well as Pfizer’s Paxlovid.
Japan
Posted inClinical Trials, Infections, Rare/Orphan Diseases
Olorofim: New Antifungal Drug
Olorophim by F2G and Shionogi & Co. is focused on invasive aspergillosis treatment.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Covifenz: Medicago’s Plant-Derived COVID-19 Vaccine
Innovative Medicago’s vaccine is made by molecular pharming technology.
Posted inInfections, Regulatory
Voquezna: New Drug for Acid-Related Gastrointestinal Diseases
Vonoprazan for Helicobacter pylori eradication and for treating erosive esophagitis, non-erosive gastroesophageal reflux disease (NERD), and gastroesophageal reflux disease (GERD).
Posted inMetabolism, New Drugs, Regulatory
Twymeeg: Completely New Drug for Treatment of Type 2 Diabetes Mellitus
Imeglimin is a universal anti-diabetic drug that incorporates the power of all existing glucose-lowering drugs.
Posted inClinical Trials, Metabolism, Neuroscience, Rare/Orphan Diseases
Redasemtide: Universal Medicine for Regeneration of Any Tissue
Redasemtide as a lifesaver for the most devastating diseases, including stroke, osteoarthritis, cardiomyopathy, and bullous epidermolysis.
Posted inNeuroscience, New Drugs, Regulatory
Lyfnua: First Drug for Refractory or Unexplained Chronic Cough
Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.